Career history of Marlies Sproll
Former positions of Marlies Sproll
| Companies | Position | Start | End |
|---|---|---|---|
| MORPHOSYS AG | Chief Tech/Sci/R&D Officer | 2010-05-18 | 2017-04-14 |
Lanthio Pharma BV
 Lanthio Pharma BV Medical SpecialtiesHealth Technology Lanthio Pharma BV focuses on discovering and developing lantipeptides for the generation of novel peptide therapeutics. Its product is a lanthionine-stabilized specific agonist of the AT2 receptor, which has great potential in diseases where tissue protection is important, like fibrosis. The company was founded in 2010 and is headquartered in Groningen, the Netherlands. | Director/Board Member | - | - |
Training of Marlies Sproll
| Max Planck Institute for Metals Research | Doctorate Degree |
Statistics
International
| Germany | 3 |
| Netherlands | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
| Director/Board Member | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| MORPHOSYS AG | Health Technology |
| Private companies | 1 |
|---|---|
Lanthio Pharma BV
Lanthio Pharma BV Medical SpecialtiesHealth Technology Lanthio Pharma BV focuses on discovering and developing lantipeptides for the generation of novel peptide therapeutics. Its product is a lanthionine-stabilized specific agonist of the AT2 receptor, which has great potential in diseases where tissue protection is important, like fibrosis. The company was founded in 2010 and is headquartered in Groningen, the Netherlands. | Health Technology |
- Stock Market
- Insiders
- Marlies Sproll
- Experience
